A dual effect of some 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon

Pierluigi Navarra, Maria Martire, Giacomo Pozzoli, Paolo Preziosi, R Del Carmine

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

3 Citazioni (Scopus)

Abstract

In the present study, the emetic effect of the anticancer drug cisplatin, and protective effects of 5-HT3 receptor antagonists against cisplatin emesis were investigated in the pigeon. The experimental setting involved the i.v. administration of drugs and subsequent observation of the percentage of vomiting animals and number of emetic episodes per vomiting animal over a period of 5 h. In some experiments, the 5-HT and 5-HIAA content in tissues was estimated by the HPLC technique. It was observed that cisplatin (2.5-10 mg/kg) is able to induce dose-dependent emesis in the pigeon. 5-HT3 receptor antagonists (500 micrograms/kg) afford partial protection against cisplatin emesis, although some of them, i.e. indolic derivatives and zacopride, display intrinsic emetic activity at doses of 50-500 micrograms/kg. A serotonergic mechanism appears to be involved in both cisplatin- and 5-HT3 receptor antagonist-induced emesis, since pretreatment with an inhibitor of 5-HT synthesis, para-chlorophenylalanine (300 mg/kg x 3 days), is able to hamper vomiting induced by either cisplatin or 5-HT3 receptor antagonists. It is concluded that the intrinsic emetic effects of 5-HT3 receptor antagonists in the pigeon provide pharmacological evidence of species differences in the properties of 5 HT3 receptors.
Lingua originaleEnglish
pagine (da-a)745-749
Numero di pagine5
RivistaToxicology Letters
Volume64-65 Spec No
Stato di pubblicazionePubblicato - 1992

Keywords

  • Animals
  • Antiemetics
  • Cisplatin
  • Columbidae
  • Female
  • Male
  • Serotonin Antagonists
  • Vomiting

Fingerprint Entra nei temi di ricerca di 'A dual effect of some 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon'. Insieme formano una fingerprint unica.

Cita questo